Cargando…
Prevalence of aortic stenosis and TAVR outcomes in patients with systemic sclerosis‐associated pulmonary hypertension
There is little known about performing transcatheter aortic valve replacement (TAVR) in patients with group 1 pulmonary arterial hypertension (PAH) on advanced pulmonary vasodilator therapy. Retrospective cohort study among 90 patients with systemic sclerosis‐associated pulmonary arterial hypertensi...
Autores principales: | Alman, Kirsten, Sadd, Corey J., Ravel, Amish, Raza, Farhan, Chybowski, Amy, Runo, James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400580/ https://www.ncbi.nlm.nih.gov/pubmed/36034401 http://dx.doi.org/10.1002/pul2.12118 |
Ejemplares similares
-
Interferon-β–Induced Pulmonary Arterial Hypertension: Approach to Diagnosis and Clinical Monitoring
por: Raza, Farhan, et al.
Publicado: (2021) -
TAVR and SAVR: Current Treatment of Aortic Stenosis
por: Hu, Patrick P.
Publicado: (2012) -
Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest V
(E)/VCO(2) and ETCO(2) identify pulmonary vascular disease
por: Raza, Farhan, et al.
Publicado: (2022) -
Comparison of Sutureless Bioprosthetic Valve With Surgical or TAVR for Severe Aortic Stenosis
por: Kim, Ho Jin, et al.
Publicado: (2021) -
Comparative Outcomes of TAVR in Mixed Aortic Valve Disease and Aortic Stenosis: A Meta-analysis
por: Ugwu, Justin K., et al.
Publicado: (2022)